Cargando…
The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
Patients with chronic kidney disease (CKD) are more prone to oxidative stress and chronic inflammation, which may lead to an increase in the synthesis of advanced glycation end products (AGEs). Because AGEs are mostly removed by healthy kidneys, AGE accumulation is a result of both increased product...
Autores principales: | Steenbeke, Mieke, Speeckaert, Reinhart, Desmedt, Stéphanie, Glorieux, Griet, Delanghe, Joris R., Speeckaert, Marijn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998875/ https://www.ncbi.nlm.nih.gov/pubmed/35408796 http://dx.doi.org/10.3390/ijms23073439 |
Ejemplares similares
-
Dietary Advanced Glycation End Products in an Elderly Population with Diabetic Nephropathy: An Exploratory Investigation
por: Steenbeke, Mieke, et al.
Publicado: (2022) -
UV Fluorescence-Based Determination of Urinary Advanced Glycation End Products in Patients with Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2020) -
The Potential Influence of Advanced Glycation End Products and (s)RAGE in Rheumatic Diseases
por: Delrue, Charlotte, et al.
Publicado: (2023) -
Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2021) -
Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2020)